AP Technology Unveils Breast Milk Oligosaccharides at Seoul International Food Industry Exhibition

[Asia Economy Reporter Hyungsoo Park] AP Technology announced on the 8th that it will participate in the ‘2022 Seoul International Food Industry Exhibition’ held at KINTEX in Ilsan until the 10th.

Marking its 40th anniversary this year, Seoul Food is one of Asia's four major food industry exhibitions hosted by the Korea Trade-Investment Promotion Agency (KOTRA). It actively supports the establishment of overseas supply chains for domestic food industry companies facing difficulties in expanding abroad due to the COVID-19 pandemic. Various business-to-business (B2B) support programs and one-on-one consultations with major domestic and international buyers are organized and operated.

At the exhibition, AP Technology will mainly introduce human milk oligosaccharides (HMO). HMO is one of the various components of breast milk involved in suppressing the secretion of inflammatory substances, forming beneficial gut bacteria, and brain development. AP Technology secured differentiated competitiveness in domestic and international markets by being the first in the world to produce ‘2’-FL (2’-Fucosyllactose)’, a core component of HMO.

An AP Technology official stated, "To secure overseas market dominance, we are expanding sales channels beyond existing markets such as the United States and Southeast Asia to Europe and the Arab region," and added, "We will actively communicate with major domestic and international buyers and companies through the exhibition and showcase our differentiated technology."

He continued, "This year, we expect annual sales to increase more than fourfold compared to the previous year by focusing on exports."

This content was produced with the assistance of AI translation services.